Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies

@article{LilienfeldToal2006ChangeOP,
  title={Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies},
  author={Marie von Lilienfeld-Toal and Astrid Schneider and Katjana S Orlopp and Corinna Hahn-Ast and Axel Glasmacher and Frank Stueber},
  journal={Supportive Care in Cancer},
  year={2006},
  volume={14},
  pages={1241-1245}
}
Procalcitonin (PCT) was widely investigated in febrile neutropenia as an indirect marker of infection. Many institutions also use PCT as a tool to monitor the course of a febrile episode because increases in PCT values during the febrile episode were associated with development of complications. However, to date, no study systematically evaluated the accuracy of decreasing PCT values in predicting favorable outcomes of a febrile episode. The aim of this study was to evaluate the changes in PCT… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
10 Citations
22 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Similar Papers

Loading similar papers…